| protein ubiquitination | GO:0016567 | 314 | 0.952 | Human |
| neural tube formation | GO:0001841 | 3 | 0.886 | |
| protein polyubiquitination | GO:0000209 | 110 | 0.878 | Human |
| embryonic epithelial tube formation | GO:0001838 | 4 | 0.808 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.640 | |
| protein deubiquitination | GO:0016579 | 79 | 0.614 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.531 | Human |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.444 | Human |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.419 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.414 | |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 156 | 0.347 | |
| primary neural tube formation | GO:0014020 | 3 | 0.334 | |
| regulation of stress activated mapk cascade | GO:0032872 | 84 | 0.332 | |
| jnk cascade | GO:0007254 | 80 | 0.330 | |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 162 | 0.323 | Human |
| post embryonic development | GO:0009791 | 2 | 0.316 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.300 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 166 | 0.280 | Human |
| chromatin organization | GO:0006325 | 351 | 0.249 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 94 | 0.241 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.220 | |
| protein k63 linked ubiquitination | GO:0070534 | 31 | 0.215 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.214 | Human |
| vesicle mediated transport | GO:0016192 | 371 | 0.210 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.209 | Human |
| regulation of defense response | GO:0031347 | 154 | 0.206 | Human |
| dna repair | GO:0006281 | 198 | 0.194 | |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.193 | |
| regulation of jnk cascade | GO:0046328 | 73 | 0.193 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.185 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.182 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 206 | 0.182 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.174 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.174 | Human |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.170 | |
| mapk cascade | GO:0000165 | 288 | 0.170 | |
| chromatin modification | GO:0016568 | 298 | 0.164 | |
| regulation of protein localization | GO:0032880 | 296 | 0.157 | Human |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.150 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.149 | |
| negative regulation of organelle organization | GO:0010639 | 126 | 0.149 | |
| positive regulation of i kappab kinase nf kappab signaling | GO:0043123 | 132 | 0.143 | |
| histone h2a ubiquitination | GO:0033522 | 17 | 0.142 | |
| histone ubiquitination | GO:0016574 | 31 | 0.140 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.140 | Human |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.138 | Human |
| cellular protein catabolic process | GO:0044257 | 261 | 0.138 | |
| activation of jnkk activity | GO:0007256 | 1 | 0.134 | |
| regulation of stress activated protein kinase signaling cascade | GO:0070302 | 85 | 0.128 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.126 | |
| regulation of protein transport | GO:0051223 | 213 | 0.125 | |
| neural tube closure | GO:0001843 | 3 | 0.121 | |
| negative regulation of multi organism process | GO:0043901 | 92 | 0.121 | Human |
| negative regulation of chromosome organization | GO:2001251 | 48 | 0.121 | |
| response to cytokine | GO:0034097 | 232 | 0.118 | |
| stress activated mapk cascade | GO:0051403 | 93 | 0.117 | |
| protein modification by small protein removal | GO:0070646 | 92 | 0.117 | |
| tube closure | GO:0060606 | 3 | 0.117 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.115 | |
| regulation of microtubule cytoskeleton organization | GO:0070507 | 61 | 0.113 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.113 | |
| positive regulation of mapk cascade | GO:0043410 | 190 | 0.109 | |
| protein k48 linked ubiquitination | GO:0070936 | 38 | 0.104 | Human |
| hindbrain development | GO:0030902 | 3 | 0.103 | |
| regulation of glutamine family amino acid metabolic process | GO:0000820 | 2 | 0.100 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.098 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.096 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.096 | |
| negative regulation of protein ubiquitination | GO:0031397 | 35 | 0.095 | Human |
| defense response | GO:0006952 | 315 | 0.093 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.093 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.093 | Human |
| positive regulation of developmental process | GO:0051094 | 314 | 0.091 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.090 | |
| regulation of neurotransmitter secretion | GO:0046928 | 3 | 0.088 | |
| peptidyl lysine modification | GO:0018205 | 144 | 0.086 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.083 | Human |
| determination of adult lifespan | GO:0008340 | 2 | 0.083 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.082 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.082 | Human |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.081 | |
| microtubule cytoskeleton organization | GO:0000226 | 176 | 0.081 | |
| regulation of microtubule based process | GO:0032886 | 74 | 0.081 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.081 | |
| protein targeting | GO:0006605 | 187 | 0.081 | |
| protein complex disassembly | GO:0043241 | 52 | 0.079 | |
| microtubule organizing center organization | GO:0031023 | 62 | 0.078 | |
| regulation of ras protein signal transduction | GO:0046578 | 155 | 0.078 | |
| regulation of immune effector process | GO:0002697 | 91 | 0.077 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.076 | |
| locomotory behavior | GO:0007626 | 1 | 0.076 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.076 | |
| histone modification | GO:0016570 | 251 | 0.076 | |
| protein autoubiquitination | GO:0051865 | 37 | 0.076 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 60 | 0.074 | |
| cerebral cortex radially oriented cell migration | GO:0021799 | 1 | 0.073 | |
| maintenance of location in cell | GO:0051651 | 62 | 0.070 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.070 | |
| cell adhesion | GO:0007155 | 325 | 0.070 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.069 | |
| regulation of chromosome organization | GO:0033044 | 103 | 0.068 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.066 | |
| regulation of synaptic vesicle exocytosis | GO:2000300 | 2 | 0.066 | |
| intracellular protein transport | GO:0006886 | 270 | 0.066 | |
| cytokine production | GO:0001816 | 247 | 0.066 | Human |
| response to growth factor | GO:0070848 | 205 | 0.065 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.065 | |
| organelle localization | GO:0051640 | 84 | 0.065 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.064 | |
| microtubule based process | GO:0007017 | 210 | 0.064 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.062 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.061 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.061 | |
| negative regulation of protein polyubiquitination | GO:1902915 | 4 | 0.060 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.060 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.059 | |
| protein catabolic process | GO:0030163 | 325 | 0.058 | |
| regulation of cytoplasmic transport | GO:1903649 | 149 | 0.058 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.057 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.057 | |
| negative regulation of defense response | GO:0031348 | 47 | 0.057 | |
| regulation of microtubule polymerization or depolymerization | GO:0031110 | 27 | 0.056 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 0.056 | Human |
| neurotransmitter secretion | GO:0007269 | 4 | 0.056 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.056 | |
| cellular component disassembly | GO:0022411 | 92 | 0.056 | |
| negative regulation of immune system process | GO:0002683 | 136 | 0.055 | Human |
| response to external biotic stimulus | GO:0043207 | 261 | 0.055 | Human |
| multicellular organismal homeostasis | GO:0048871 | 67 | 0.055 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.054 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.054 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.053 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.052 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.052 | |
| glutamate metabolic process | GO:0006536 | 10 | 0.051 | |
| regulation of response to dna damage stimulus | GO:2001020 | 94 | 0.051 | |
| protein acylation | GO:0043543 | 138 | 0.050 | |
| establishment of protein localization to organelle | GO:0072594 | 172 | 0.050 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.050 | Human |
| regulation of cell motility | GO:2000145 | 299 | 0.049 | |
| cell morphogenesis | GO:0000902 | 296 | 0.049 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.049 | |
| regulation of cytoskeleton organization | GO:0051493 | 177 | 0.048 | |
| immune system development | GO:0002520 | 195 | 0.048 | Human |
| embryo development | GO:0009790 | 123 | 0.048 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 88 | 0.047 | |
| female gamete generation | GO:0007292 | 2 | 0.047 | |
| regulation of mapk cascade | GO:0043408 | 262 | 0.047 | |
| biological adhesion | GO:0022610 | 331 | 0.046 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 3 | 0.046 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.045 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 205 | 0.045 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.045 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.045 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 48 | 0.045 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.044 | |
| cell activation | GO:0001775 | 213 | 0.043 | |
| nucleus localization | GO:0051647 | 1 | 0.043 | |
| modification dependent protein catabolic process | GO:0019941 | 209 | 0.043 | |
| microtubule anchoring | GO:0034453 | 24 | 0.042 | |
| positive regulation of stress activated protein kinase signaling cascade | GO:0070304 | 61 | 0.042 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.042 | Human |
| maintenance of location | GO:0051235 | 112 | 0.042 | |
| single organismal cell cell adhesion | GO:0016337 | 148 | 0.042 | |
| regulation of chromatin organization | GO:1902275 | 56 | 0.042 | |
| positive regulation of gtp catabolic process | GO:0033126 | 166 | 0.041 | |
| regulation of odontogenesis | GO:0042481 | 4 | 0.041 | |
| canonical wnt signaling pathway involved in negative regulation of apoptotic process | GO:0044336 | 2 | 0.041 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.041 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.040 | |
| response to virus | GO:0009615 | 126 | 0.040 | |
| cell projection organization | GO:0030030 | 252 | 0.040 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 107 | 0.039 | Human |
| negative regulation of response to external stimulus | GO:0032102 | 83 | 0.039 | Human |
| wnt signaling pathway | GO:0016055 | 156 | 0.038 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.038 | |
| negative regulation of response to dna damage stimulus | GO:2001021 | 33 | 0.037 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.037 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 186 | 0.037 | |
| regulation of protein stability | GO:0031647 | 87 | 0.037 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 61 | 0.036 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 85 | 0.036 | Human |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.036 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.036 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.036 | |
| macromolecular complex disassembly | GO:0032984 | 60 | 0.036 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.035 | Human |
| positive regulation of synaptic transmission | GO:0050806 | 4 | 0.035 | |
| positive regulation of gtpase activity | GO:0043547 | 166 | 0.035 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.035 | Human |
| intracellular receptor signaling pathway | GO:0030522 | 104 | 0.035 | |
| protein k63 linked deubiquitination | GO:0070536 | 21 | 0.034 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.034 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.034 | |
| negative regulation of dna metabolic process | GO:0051053 | 57 | 0.033 | |
| defense response to virus | GO:0051607 | 71 | 0.033 | |
| hemopoiesis | GO:0030097 | 180 | 0.033 | |
| sequestering of metal ion | GO:0051238 | 24 | 0.033 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 125 | 0.033 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.033 | |
| endosome transport via multivesicular body sorting pathway | GO:0032509 | 3 | 0.033 | |
| regulation of protein localization to nucleus | GO:1900180 | 85 | 0.032 | Human |
| negative regulation of protein modification by small protein conjugation or removal | GO:1903321 | 41 | 0.032 | Human |
| cellular response to organonitrogen compound | GO:0071417 | 124 | 0.032 | |
| peptidyl lysine acetylation | GO:0018394 | 101 | 0.032 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.032 | |
| negative regulation of striated muscle contraction | GO:0045988 | 2 | 0.032 | |
| mitotic cytokinesis | GO:0000281 | 19 | 0.032 | |
| negative regulation of proteolysis | GO:0045861 | 132 | 0.032 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.032 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.032 | |
| oogenesis | GO:0048477 | 2 | 0.032 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 87 | 0.032 | |
| reproductive system development | GO:0061458 | 56 | 0.032 | |
| cerebral cortex cell migration | GO:0021795 | 3 | 0.031 | |
| proteasomal protein catabolic process | GO:0010498 | 176 | 0.030 | |
| oocyte differentiation | GO:0009994 | 2 | 0.030 | |
| protein oligomerization | GO:0051259 | 173 | 0.030 | |
| response to oxidative stress | GO:0006979 | 121 | 0.030 | |
| protein localization to organelle | GO:0033365 | 280 | 0.030 | Human |
| intracellular mrna localization | GO:0008298 | 1 | 0.030 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.030 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.030 | |
| regulation of intracellular protein transport | GO:0033157 | 123 | 0.030 | |
| regulation of immune response | GO:0050776 | 201 | 0.029 | Human |
| nuclear migration | GO:0007097 | 1 | 0.029 | |
| actin filament based process | GO:0030029 | 224 | 0.029 | |
| amine metabolic process | GO:0009308 | 44 | 0.029 | |
| negative regulation of chromatin modification | GO:1903309 | 21 | 0.029 | |
| negative regulation of immune effector process | GO:0002698 | 38 | 0.029 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.029 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 158 | 0.029 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.029 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.029 | Human |
| regulation of dendrite morphogenesis | GO:0048814 | 11 | 0.028 | |
| dna packaging | GO:0006323 | 77 | 0.028 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.028 | |
| lysosomal transport | GO:0007041 | 33 | 0.028 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.028 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 97 | 0.028 | Human |
| regulation of gtp catabolic process | GO:0033124 | 180 | 0.028 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.028 | |
| immune effector process | GO:0002252 | 159 | 0.028 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.028 | |
| tube development | GO:0035295 | 125 | 0.028 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.028 | |
| regulation of protein ubiquitination | GO:0031396 | 95 | 0.027 | Human |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.027 | |
| negative regulation of protein maturation | GO:1903318 | 142 | 0.027 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.027 | |
| endosomal transport | GO:0016197 | 129 | 0.027 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.027 | |
| nuclear import | GO:0051170 | 106 | 0.026 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.026 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.026 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.026 | |
| regulation of cell activation | GO:0050865 | 125 | 0.026 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.026 | |
| regulation of protein polyubiquitination | GO:1902914 | 8 | 0.026 | |
| cell fate determination | GO:0001709 | 3 | 0.026 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 76 | 0.025 | |
| negative regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043154 | 46 | 0.025 | |
| maintenance of protein location | GO:0045185 | 57 | 0.025 | |
| negative regulation of nf kappab transcription factor activity | GO:0032088 | 51 | 0.025 | Human |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 119 | 0.025 | |
| male meiosis | GO:0007140 | 1 | 0.025 | |
| activation of protein kinase activity | GO:0032147 | 90 | 0.025 | |
| cellular homeostasis | GO:0019725 | 196 | 0.025 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 72 | 0.025 | |
| protein acetylation | GO:0006473 | 116 | 0.025 | |
| double strand break repair | GO:0006302 | 101 | 0.025 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.025 | |
| release of cytoplasmic sequestered nf kappab | GO:0008588 | 4 | 0.025 | |
| protein localization to adherens junction | GO:0071896 | 2 | 0.025 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.024 | |
| protein k48 linked deubiquitination | GO:0071108 | 19 | 0.024 | Human |
| endocytosis | GO:0006897 | 159 | 0.024 | |
| regulation of cell migration | GO:0030334 | 289 | 0.024 | |
| protein depolymerization | GO:0051261 | 30 | 0.024 | |
| microtubule polymerization or depolymerization | GO:0031109 | 37 | 0.024 | |
| nuclear transport | GO:0051169 | 179 | 0.024 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.024 | Human |
| regulation of protein targeting | GO:1903533 | 91 | 0.024 | |
| cellular calcium ion homeostasis | GO:0006874 | 117 | 0.024 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 70 | 0.024 | |
| regulation of defense response to virus | GO:0050688 | 33 | 0.024 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.024 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.024 | |
| myeloid cell differentiation | GO:0030099 | 117 | 0.024 | |
| positive regulation of transport | GO:0051050 | 336 | 0.023 | |
| cellular response to misfolded protein | GO:0071218 | 2 | 0.023 | |
| immune response | GO:0006955 | 307 | 0.023 | |
| protein import into nucleus | GO:0006606 | 104 | 0.023 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.023 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.023 | |
| negative regulation of protein k63 linked ubiquitination | GO:1900045 | 4 | 0.023 | |
| neuron projection development | GO:0031175 | 106 | 0.023 | |
| regulation of response to cytokine stimulus | GO:0060759 | 46 | 0.023 | |
| forebrain generation of neurons | GO:0021872 | 3 | 0.023 | |
| regulation of protein complex assembly | GO:0043254 | 147 | 0.023 | |
| immune response activating signal transduction | GO:0002757 | 90 | 0.023 | Human |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.022 | |
| rna transport | GO:0050658 | 39 | 0.022 | |
| organic acid biosynthetic process | GO:0016053 | 97 | 0.022 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.022 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.022 | |
| neuroblast proliferation | GO:0007405 | 4 | 0.022 | |
| gtp metabolic process | GO:0046039 | 239 | 0.022 | |
| morphogenesis of an epithelium | GO:0002009 | 60 | 0.022 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 128 | 0.022 | |
| response to decreased oxygen levels | GO:0036293 | 96 | 0.022 | |
| positive regulation of lipopolysaccharide mediated signaling pathway | GO:0031666 | 4 | 0.022 | |
| cellular response to organic cyclic compound | GO:0071407 | 127 | 0.022 | |
| regulation of embryonic development | GO:0045995 | 20 | 0.021 | |
| response to hormone | GO:0009725 | 175 | 0.021 | |
| cellular chemical homeostasis | GO:0055082 | 180 | 0.021 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.021 | |
| tachykinin receptor signaling pathway | GO:0007217 | 3 | 0.021 | |
| synaptic vesicle exocytosis | GO:0016079 | 3 | 0.021 | |
| regulation of endosome size | GO:0051036 | 3 | 0.021 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 127 | 0.021 | |
| regulation of cell adhesion | GO:0030155 | 166 | 0.021 | |
| mrna transport | GO:0051028 | 30 | 0.021 | |
| erk1 and erk2 cascade | GO:0070371 | 104 | 0.021 | |
| prostate gland development | GO:0030850 | 3 | 0.021 | |
| single organism cell adhesion | GO:0098602 | 179 | 0.021 | |
| regulation of leukocyte activation | GO:0002694 | 115 | 0.021 | |
| reproductive structure development | GO:0048608 | 55 | 0.021 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.021 | Human |
| epithelial cell development | GO:0002064 | 34 | 0.021 | |
| metencephalon development | GO:0022037 | 2 | 0.020 | |
| cardiovascular system development | GO:0072358 | 262 | 0.020 | |
| regulation of t cell activation | GO:0050863 | 77 | 0.020 | |
| regulation of secretion by cell | GO:1903530 | 177 | 0.020 | |
| anterior posterior axis specification | GO:0009948 | 2 | 0.020 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 2 | 0.020 | |
| taxis | GO:0042330 | 157 | 0.020 | |
| secretion by cell | GO:0032940 | 226 | 0.020 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 91 | 0.020 | |
| protein homooligomerization | GO:0051260 | 100 | 0.020 | |
| tissue homeostasis | GO:0001894 | 63 | 0.020 | |
| negative regulation of protein complex disassembly | GO:0043242 | 20 | 0.020 | |
| sensory perception of sweet taste | GO:0050916 | 2 | 0.020 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 2 | 0.020 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.020 | Human |
| maintenance of protein location in cell | GO:0032507 | 56 | 0.020 | |
| intracellular estrogen receptor signaling pathway | GO:0030520 | 23 | 0.020 | |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.020 | |
| single organism cellular localization | GO:1902580 | 332 | 0.020 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.020 | |
| ion homeostasis | GO:0050801 | 230 | 0.019 | |
| regulation of innate immune response | GO:0045088 | 97 | 0.019 | Human |
| epithelial tube formation | GO:0072175 | 5 | 0.019 | |
| reproductive process | GO:0022414 | 106 | 0.019 | |
| regulation of vesicle mediated transport | GO:0060627 | 130 | 0.019 | |
| chromatin assembly or disassembly | GO:0006333 | 78 | 0.019 | |
| negative regulation of protein transport | GO:0051224 | 75 | 0.019 | |
| establishment of nucleus localization | GO:0040023 | 1 | 0.019 | |
| regulation of double strand break repair | GO:2000779 | 22 | 0.019 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 191 | 0.019 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 186 | 0.018 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.018 | |
| nucleic acid transport | GO:0050657 | 39 | 0.018 | |
| regulation of hemoglobin biosynthetic process | GO:0046984 | 1 | 0.018 | |
| methylation | GO:0032259 | 106 | 0.018 | |
| positive regulation of immune response | GO:0050778 | 159 | 0.018 | Human |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.018 | |
| regulation of chromatin modification | GO:1903308 | 51 | 0.018 | |
| single organism reproductive process | GO:0044702 | 98 | 0.018 | |
| epithelium development | GO:0060429 | 227 | 0.018 | |
| fatty acid biosynthetic process | GO:0006633 | 46 | 0.018 | |
| maintenance of cell polarity | GO:0030011 | 2 | 0.018 | |
| negative regulation of kinase activity | GO:0033673 | 106 | 0.018 | |
| negative regulation of protein depolymerization | GO:1901880 | 17 | 0.018 | |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.018 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.018 | |
| response to uv | GO:0009411 | 73 | 0.018 | |
| muscle cell cellular homeostasis | GO:0046716 | 3 | 0.017 | |
| cellular response to decreased oxygen levels | GO:0036294 | 51 | 0.017 | |
| positive regulation of ras gtpase activity | GO:0032320 | 117 | 0.017 | |
| response to wounding | GO:0009611 | 168 | 0.017 | |
| rna localization | GO:0006403 | 41 | 0.017 | |
| negative regulation of microtubule polymerization or depolymerization | GO:0031111 | 17 | 0.017 | |
| gtp catabolic process | GO:0006184 | 237 | 0.017 | |
| coenzyme metabolic process | GO:0006732 | 65 | 0.017 | |
| protein localization to lysosome | GO:0061462 | 11 | 0.017 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 69 | 0.017 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 156 | 0.017 | |
| positive regulation of defense response | GO:0031349 | 87 | 0.017 | Human |
| golgi vesicle transport | GO:0048193 | 80 | 0.017 | |
| positive regulation of t cell cytokine production | GO:0002726 | 4 | 0.017 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.017 | |
| positive regulation of mitochondrion organization | GO:0010822 | 30 | 0.017 | |
| aging | GO:0007568 | 66 | 0.017 | |
| carboxylic acid biosynthetic process | GO:0046394 | 97 | 0.017 | |
| regulation of locomotion | GO:0040012 | 329 | 0.017 | |
| developmental programmed cell death | GO:0010623 | 3 | 0.017 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.016 | |
| dna conformation change | GO:0071103 | 113 | 0.016 | |
| secretion | GO:0046903 | 254 | 0.016 | |
| cerebral cortex radial glia guided migration | GO:0021801 | 1 | 0.016 | |
| viral process | GO:0016032 | 146 | 0.016 | |
| negative regulation of synaptic transmission | GO:0050805 | 2 | 0.016 | |
| regulation of membrane potential | GO:0042391 | 95 | 0.016 | |
| regulation of ubiquitin protein transferase activity | GO:0051438 | 28 | 0.016 | |
| regulation of cytokine production | GO:0001817 | 232 | 0.016 | Human |
| cellular response to nitrogen compound | GO:1901699 | 144 | 0.016 | |
| cerebellum development | GO:0021549 | 2 | 0.016 | |
| response to endoplasmic reticulum stress | GO:0034976 | 49 | 0.016 | |
| cellular metal ion homeostasis | GO:0006875 | 146 | 0.016 | |
| organ morphogenesis | GO:0009887 | 147 | 0.016 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.016 | |
| t cell activation | GO:0042110 | 99 | 0.016 | |
| oocyte development | GO:0048599 | 1 | 0.016 | |
| regulation of homeostatic process | GO:0032844 | 121 | 0.016 | |
| hemostasis | GO:0007599 | 76 | 0.016 | |
| regulation of secretion | GO:0051046 | 194 | 0.016 | |
| ameboidal type cell migration | GO:0001667 | 135 | 0.016 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 90 | 0.015 | |
| positive regulation of fibroblast growth factor receptor signaling pathway | GO:0045743 | 3 | 0.015 | |
| leukocyte activation | GO:0045321 | 164 | 0.015 | |
| cell development | GO:0048468 | 328 | 0.015 | |
| histone acetylation | GO:0016573 | 93 | 0.015 | |
| regulation of leukocyte differentiation | GO:1902105 | 61 | 0.015 | |
| activation of mapkk activity | GO:0000186 | 18 | 0.015 | |
| protein autophosphorylation | GO:0046777 | 123 | 0.015 | |
| embryonic hemopoiesis | GO:0035162 | 4 | 0.015 | |
| muscle system process | GO:0003012 | 81 | 0.015 | |
| jak stat cascade | GO:0007259 | 46 | 0.015 | |
| monocarboxylic acid metabolic process | GO:0032787 | 185 | 0.015 | |
| blood vessel development | GO:0001568 | 172 | 0.015 | |
| regulation of cell cell adhesion | GO:0022407 | 57 | 0.015 | |
| microtubule depolymerization | GO:0007019 | 18 | 0.015 | |
| nucleotide binding oligomerization domain containing signaling pathway | GO:0070423 | 4 | 0.015 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 179 | 0.015 | |
| regulation of response to biotic stimulus | GO:0002831 | 55 | 0.015 | Human |
| regulation of histone modification | GO:0031056 | 47 | 0.015 | |
| regulation of lipopolysaccharide mediated signaling pathway | GO:0031664 | 13 | 0.014 | Human |
| spermatid development | GO:0007286 | 4 | 0.014 | |
| cell projection morphogenesis | GO:0048858 | 129 | 0.014 | |
| protein localization to nucleus | GO:0034504 | 136 | 0.014 | Human |
| regulation of erk1 and erk2 cascade | GO:0070372 | 99 | 0.014 | |
| post embryonic organ development | GO:0048569 | 1 | 0.014 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 159 | 0.014 | |
| regulation of meiotic cell cycle | GO:0051445 | 4 | 0.014 | |
| circulatory system development | GO:0072359 | 262 | 0.014 | |
| system process | GO:0003008 | 349 | 0.014 | |
| regulation of immunoglobulin production | GO:0002637 | 4 | 0.014 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 75 | 0.014 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 55 | 0.014 | |
| establishment or maintenance of cell polarity | GO:0007163 | 31 | 0.014 | |
| scf dependent proteasomal ubiquitin dependent protein catabolic process | GO:0031146 | 15 | 0.014 | |
| immunoglobulin secretion | GO:0048305 | 1 | 0.014 | |
| regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902108 | 18 | 0.014 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 18 | 0.014 | |
| cell projection assembly | GO:0030031 | 126 | 0.014 | |
| patterning of blood vessels | GO:0001569 | 2 | 0.014 | |
| spermatid differentiation | GO:0048515 | 4 | 0.014 | |
| anatomical structure homeostasis | GO:0060249 | 100 | 0.014 | |
| neurogenesis | GO:0022008 | 169 | 0.014 | |
| regulation of nucleoside metabolic process | GO:0009118 | 209 | 0.014 | |
| chromatin assembly | GO:0031497 | 61 | 0.014 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.014 | |
| positive regulation of mitochondrial fission | GO:0090141 | 7 | 0.014 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 28 | 0.014 | |
| positive regulation of wnt signaling pathway | GO:0030177 | 54 | 0.014 | |
| response to lipid | GO:0033993 | 206 | 0.014 | Human |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.013 | |
| response to metal ion | GO:0010038 | 84 | 0.013 | |
| establishment or maintenance of bipolar cell polarity | GO:0061245 | 2 | 0.013 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 82 | 0.013 | |
| regulation of epithelial cell migration | GO:0010632 | 93 | 0.013 | |
| angiogenesis | GO:0001525 | 147 | 0.013 | |
| neurological system process | GO:0050877 | 163 | 0.013 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 187 | 0.013 | |
| innate immune response | GO:0045087 | 178 | 0.013 | |
| embryonic hindlimb morphogenesis | GO:0035116 | 2 | 0.013 | |
| response to disaccharide | GO:0034285 | 1 | 0.013 | |
| response to light stimulus | GO:0009416 | 87 | 0.013 | |
| immune response regulating signaling pathway | GO:0002764 | 97 | 0.013 | Human |
| cellular response to lipopolysaccharide | GO:0071222 | 57 | 0.013 | Human |
| neuron development | GO:0048666 | 113 | 0.013 | |
| pharynx development | GO:0060465 | 1 | 0.013 | |
| regulation of protein maturation | GO:1903317 | 150 | 0.013 | |
